JHL Biotech's Final Trading Day on Taipei Exchange
HSINCHU and WUHAN, China, Feb. 12, 2018 /PRNewswire/ -- JHL Biotech
JHL Biotech Welcomes New Chief Medical Officer, Rong Chen
HSINCHU and WUHAN, China, Jan. 2, 2018 /PRNewswire/ -- JHL Biotech
JHL Biotech Receives Approval From European Authorities to Begin Biosimilar Clinical Trial
HSINCHU, , Feb. 15, 2016 /PRNewswire/ -- JHL Biotech, Inc. (Stock Code: 6540.TWO) announced it has received authorization from theUnited Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to begin clinical trial for JHL1101, a rituximab biosimilar developed and manufactured ...